Zydus Lifesciences Corporate Filings & Announcements

Latest corporate announcements and filings from Zydus Lifesciences on BSE

Search Inside the pdf :

Zydus Lifesciences Ltd.

20 Jul 2026, 12:54PM

1143.10

-0.51%

Board Meeting

Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results for the quarter ended on June 30, 2026.

pdf

Zydus Lifesciences Ltd.

15 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Reply To The Clarification Sought From The Company

BSE India

Reply to the clarification sought from the company

pdf

Zydus Lifesciences Ltd.

14 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Clarification sought from Zydus Lifesciences Ltd

BSE India

The Exchange has sought Clarification from Zydus Lifesciences Ltd with reference to the media report appearing on https://www.ndtvprofit.com dated July 14, 2026, (Link: https://www.ndtvprofit.com/business/delhi-high-court-temporarily-restricts-supply-of-zydus-cancer-drug-ikra-in-abbvie-patent-dispute-11764992) titled "Delhi HC Temporarily Restricts Supply of Zydus Cancer Drug Ikra In AbbVie Patent Dispute"The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015.

Zydus Lifesciences Ltd.

11 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

The newspaper cutting dated July 11, 2026, with regard to Notice of 31st Annual General Meeting of the Company published in the Financial Express.

pdf

Zydus Lifesciences Ltd.

10 Jul 2026

1143.10

-0.51%

Corp. Note

Zydus Lifesciences Ltd - 532321 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Business Responsibility and Sustainability Report for the financial year ended on March 31, 2026

pdf

Zydus Lifesciences Ltd.

10 Jul 2026

1143.10

-0.51%

Corp. Note

Zydus Lifesciences Ltd - 532321 - Reg. 34 (1) Annual Report.

BSE India

Integrated Annual Report for the FY 2025-26

pdf

Zydus Lifesciences Ltd.

10 Jul 2026

1143.10

-0.51%

AGM

Zydus Lifesciences Ltd - 532321 - Notice Of Annual General Meeting

BSE India

Notice of Annual General Meeting

pdf

Zydus Lifesciences Ltd.

09 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

The newspaper advertisement published in the Financial Express English and Gujarati edition with regard to the Notice to the shareholders for claiming their shares which are proposed to be transferred to Investor Education and Protection Fund.

pdf

Zydus Lifesciences Ltd.

08 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2026

pdf

Zydus Lifesciences Ltd.

04 Jul 2026

1143.10

-0.51%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper cutting dated July 4, 2026 with regard to Notice and information of 31st Annual General Meeting of the Company published in the Financial Express.

pdf

Is Cadila Healthcare Ltd. worth buying?

875 Votes:

Buy 81.94%

Sell 10.06%

Hold 8.0%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf